These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2458480)

  • 41. Noradrenergic modulation of 4-aminopyridine-induced acetylcholine release from rat cerebral cortex.
    Magnani M; Mantovani P; Pepeu G
    Pharmacol Res Commun; 1985 Jul; 17(7):653-8. PubMed ID: 2996031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation.
    Vizi ES; Somogyi GT; Harsing LG; Zimanyi I
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8775-9. PubMed ID: 2867546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Research progress on a new potassium channel-blocking agent--4-aminopyridine].
    Zheng W; Zhang YP
    Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):254-8. PubMed ID: 2432655
    [No Abstract]   [Full Text] [Related]  

  • 44. [Blockade of potassium membrane permeability and analgesic action of various compounds].
    Lavretskaia EF; Metkalova SE
    Izv Akad Nauk SSSR Biol; 1988; (3):368-73. PubMed ID: 2457607
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of potassium channel blockade on endogenous glutamate release from cerebellar slices.
    Barnes S; Whitham EM; Davies JA
    Brain Res; 1989 May; 486(1):89-94. PubMed ID: 2566364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of age on presynaptic alpha 2 adrenoceptor autoregulation of norepinephrine release.
    Daly RN; Goldberg PB; Roberts J
    J Gerontol; 1989 May; 44(3):B59-66. PubMed ID: 2541194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of potassium channel blockers on differentiation of Dictyostelium discoideum.
    Van Duijn B; Van der Molen LG; Ypey DL
    Pflugers Arch; 1989; 414 Suppl 1():S148-9. PubMed ID: 2550892
    [No Abstract]   [Full Text] [Related]  

  • 48. [Characteristics of the stimulating action of potassium channel blockers on neuronal activity].
    Lavretskaia EF; Balaban PM; Zakharov IS; Timashov VP
    Izv Akad Nauk SSSR Biol; 1988; (1):86-90. PubMed ID: 2450906
    [No Abstract]   [Full Text] [Related]  

  • 49. Potentiation of bovine growth hormone release by an inhibitor of potassium channels.
    Schofield JG; Saith S
    Eur J Pharmacol; 1981 Dec; 76(4):431-4. PubMed ID: 6276196
    [No Abstract]   [Full Text] [Related]  

  • 50. Reversal of xylazine in red deer.
    Mackintosh CG
    Vet Rec; 1985 Nov; 117(19):507. PubMed ID: 3001997
    [No Abstract]   [Full Text] [Related]  

  • 51. Uterine motility in the cow during the estrous cycle. III. Effects of oxytocin, xylazine, and adrenoceptor blockers.
    Rodriguez-Martinez H; McKenna D; Weston PG; Gustafsson BK; Whitmore HL
    Theriogenology; 1987 Feb; 27(2):359-68. PubMed ID: 16726241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sudden transitory diplopia following ingestion of iodocholine yohimbine-quinine].
    SEDAN J
    Rev Otoneuroophtalmol; 1950 Jan; 22(1):48-50. PubMed ID: 15424567
    [No Abstract]   [Full Text] [Related]  

  • 53. Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.
    Bourin M; Hascoët M; Colombel MC; Coutts RT; Baker GB
    J Psychiatry Neurosci; 2002 May; 27(3):178-85. PubMed ID: 12066447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The additive effects of quinine on antidepressant drugs in the forced swimming test in mice.
    Guo WY; Todd KG; Bourin M; Hascoet M
    Psychopharmacology (Berl); 1995 Sep; 121(2):173-9. PubMed ID: 8545522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of potassium channel blockade and alpha 2-adrenoceptor activation on the release of nitric oxide from non-adrenergic non-cholinergic nerves.
    De Man JG; Boeckxstaens GE; Herman AG; Pelckmans PA
    Br J Pharmacol; 1994 May; 112(1):341-5. PubMed ID: 7518308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels.
    Drukarch B; Kits KS; Leysen JE; Schepens E; Stoof JC
    Br J Pharmacol; 1989 Sep; 98(1):113-8. PubMed ID: 2553183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of K+ permeability diminishes alpha 2-adrenoceptor mediated effects on norepinephrine release.
    Zimanyi I; Folly G; Vizi ES
    J Neurosci Res; 1988 May; 20(1):102-8. PubMed ID: 2458480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that two stereochemically different alpha-2 adrenoceptors modulate norepinephrine release in rat cerebral cortex.
    Harsing LG; Vizi ES
    J Pharmacol Exp Ther; 1991 Jan; 256(1):44-9. PubMed ID: 1671099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus.
    Galzin AM; Moret C; Langer SZ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):725-32. PubMed ID: 6323679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of the release of [3H]norepinephrine from the base and body of the rat urinary bladder by endogenous adrenergic and cholinergic mechanisms.
    Somogyi GT; de Groat WC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):204-10. PubMed ID: 2170623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.